GVK Biosciences Pvt Ltd-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:GVK Biosciences Pvt Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013932
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:30
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
GVK Biosciences Pvt Ltd (GVK BIO) is a contract research organization that offers contract manufacturing and research services. The organization provides services such as discovery services, integrated programs, clinical development, contract manufacturing, formulations and informatics. It provides distribution assays, animal models, assay development and screening, regulatory affairs services, report writing services, clinical operations services, clinical pharmacology, clinical research, clinical trial outcome database, and others. GVK BIO offers contract research services to its clientele from various sectors including pharmaceutical, agrochemical, electronics, biotechnology and academics. The organization operates through offices in India, the US and the Netherlands. GVK BIO is headquartered in Hyderabad, Telangana, India.

GVK Biosciences Pvt Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
GVK Biosciences Pvt Ltd, Medical Devices Deals, 2011 to YTD 2017 9
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Aragen Bioscience Raises US$2.7 Million In Venture Financing 11
Private Equity 12
ChrysCapital Management Acquires 10% stake in GVK Bio 12
Partnerships 13
Medivir Enters into Research Agreement with GVK Biosciences 13
GVK Biosciences Forms Joint Venture with Takeda Pharma 14
Aragen Bioscience Enters Into Co-Development Agreement With Innovent Biologics For Biotherapeutic Products 15
GVK Biosciences Enters Into Research Agreement With Endo Pharma 16
GVK Biosciences Enters Into Agreement With Onconova Therapeutics To Develop New Cancer Drugs 17
GVK Biosciences Enters Into Drug Discovery Agreement With Moulder Center for Drug Discovery Research 18
Licensing Agreements 19
Aragen Bioscience Enters into Licensing Agreement with ProteoNic Biotech 19
University Of Dundee Enters Into Licensing Agreement With GVK Biosciences For Gostar 20
GVK Biosciences Extends Licensing Agreement With Astellas Pharma 21
Acquisition 22
GVK Biosciences to Acquire Vanta Bioscience for USD5 Million 22
GVK Biosciences Acquires Remaining 6.12% Stake in Inogent Labs from Dai-Ichi Karkaria 23
GVK Biosciences Acquires Aragen Bioscience, Contract Research Organization 24
GVK Biosciences Plans To Acquire Spectrum Biosciences 25
GVK Biosciences Pvt Ltd – Key Competitors 26
GVK Biosciences Pvt Ltd – Key Employees 27
GVK Biosciences Pvt Ltd – Locations And Subsidiaries 28
Head Office 28
Other Locations & Subsidiaries 28
Appendix 30
Methodology 30
About GlobalData 30
Contact Us 30
Disclaimer 30

List of Tables
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Key Facts 2
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GVK Biosciences Pvt Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
GVK Biosciences Pvt Ltd, Medical Devices Deals, 2011 to YTD 2017 9
GVK Biosciences Pvt Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Aragen Bioscience Raises US$2.7 Million In Venture Financing 11
ChrysCapital Management Acquires 10% stake in GVK Bio 12
Medivir Enters into Research Agreement with GVK Biosciences 13
GVK Biosciences Forms Joint Venture with Takeda Pharma 14
Aragen Bioscience Enters Into Co-Development Agreement With Innovent Biologics For Biotherapeutic Products 15
GVK Biosciences Enters Into Research Agreement With Endo Pharma 16
GVK Biosciences Enters Into Agreement With Onconova Therapeutics To Develop New Cancer Drugs 17
GVK Biosciences Enters Into Drug Discovery Agreement With Moulder Center for Drug Discovery Research 18
Aragen Bioscience Enters into Licensing Agreement with ProteoNic Biotech 19
University Of Dundee Enters Into Licensing Agreement With GVK Biosciences For Gostar 20
GVK Biosciences Extends Licensing Agreement With Astellas Pharma 21
GVK Biosciences to Acquire Vanta Bioscience for USD5 Million 22
GVK Biosciences Acquires Remaining 6.12% Stake in Inogent Labs from Dai-Ichi Karkaria 23
GVK Biosciences Acquires Aragen Bioscience, Contract Research Organization 24
GVK Biosciences Plans To Acquire Spectrum Biosciences 25
GVK Biosciences Pvt Ltd, Key Competitors 26
GVK Biosciences Pvt Ltd, Key Employees 27
GVK Biosciences Pvt Ltd, Other Locations 28
GVK Biosciences Pvt Ltd, Subsidiaries 28

★海外企業調査レポート[GVK Biosciences Pvt Ltd-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ngai Hing Hong Co Ltd (1047):企業の財務・戦略的SWOT分析
    Ngai Hing Hong Co Ltd (1047) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Incitec Pivot Ltd (IPL):企業の財務・戦略的SWOT分析
    Incitec Pivot Ltd (IPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Hutchison Telecommunications Hong Kong Holdings Limited (215):企業の財務・戦略的SWOT分析
    Hutchison Telecommunications Hong Kong Holdings Limited (215) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the co …
  • WPG Holdings Limited:企業の戦略・SWOT・財務情報
    WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • JEA:企業の発電所・SWOT分析2018
    JEA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), a …
  • Apartment Investment and Management Co:企業の戦略・SWOT・財務情報
    Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report Summary Apartment Investment and Management Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Arcam AB:企業の戦略的SWOT分析
    Arcam AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Terumo Corporation:企業の戦略・SWOT・財務分析
    Terumo Corporation - Strategy, SWOT and Corporate Finance Report Summary Terumo Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Medicamen Biotech Ltd (531146):企業の財務・戦略的SWOT分析
    Medicamen Biotech Ltd (531146) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Orexo AB (ORX):企業の財務・戦略的SWOT分析
    Orexo AB (ORX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • ROSEN Swiss AG:企業の戦略的SWOT分析
    ROSEN Swiss AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Arris International Plc
    Arris International Plc - Strategy, SWOT and Corporate Finance Report Summary Arris International Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Delaware Electric Cooperative Inc:企業の戦略的SWOT分析
    Delaware Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • TV Asahi Corporation (9409):企業の財務・戦略的SWOT分析
    TV Asahi Corporation (9409) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Talwalkars Better Value Fitness Ltd (TALWALKARS):企業の財務・戦略的SWOT分析
    Talwalkars Better Value Fitness Ltd (TALWALKARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • MabVax Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary MabVax Therapeutics Inc (MabVax Therapeutics), a subsidiary of MabVax Therapeutics Holdings Inc is a biopharmaceutical company that develops and commercializes anti-cancer immunotherapies from antibody and vaccine technology. The company offers immune-oncology technology platforms such as hu …
  • Bank of the Philippine Islands:企業の戦略・SWOT・財務情報
    Bank of the Philippine Islands - Strategy, SWOT and Corporate Finance Report Summary Bank of the Philippine Islands - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Jellagen Pty Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Jellagen Pty Ltd (Jellagen) is a provider of medical grade collagen products. The company’s products offer medical grade collagen supplied in the form of hydragel used in wound dressing, soft tissue regeneration, tissue engineering and haemostats. Its product pipeline offer scaffolds, which …
  • Marathon Petroleum Corporation (MPC)-石油・ガス分野:企業M&A・提携分析
    Summary Marathon Petroleum Corporation (MPC) is a downstream energy company, which refines, markets and transports petroleum products. It owns and operates refineries in the Gulf Coast and Midwest regions of the US. MPC owns common carrier pipeline systems that transport crude oil and refined produc …
  • CoreRx Inc-製薬・医療分野:企業M&A・提携分析
    Summary CoreRx Inc (CoreRx) is a contract development manufacturing organization which provides a comprehensive range of drug development services. Its products portfolio includes oral, topical, liquids or parental, ophthalmic and combined medicines. The company offers a wide range of drug product d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆